You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 11, 2026
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
1Department of Radiology, Weill Medical College of Cornell University, New York, NY 10022, USA.
This study evaluates a new imaging technique that measures brain bleeding volume more accurately than standard methods. Traditional scans often produce distorted images that change depending on scanner settings. The researchers demonstrate that this new approach provides consistent measurements regardless of imaging timing. This improvement allows for more reliable clinical assessments of patients with brain hemorrhages.
Area of Science:
Background:
No prior work had resolved the persistent issue of blooming artifacts in standard brain hemorrhage imaging. These distortions frequently obscure the true size of internal bleeding during routine diagnostic procedures. Prior research has shown that traditional gradient echo scans produce variable results based on specific timing settings. This uncertainty drove the development of advanced post-processing techniques to improve diagnostic precision. Clinicians often struggle to obtain consistent volume estimates when using conventional susceptibility-weighted imaging protocols. That gap motivated the investigation into alternative mapping methods that remain stable across different scan parameters. Current clinical standards lack a robust way to eliminate echo time dependence during routine patient evaluations. This study addresses these limitations by testing a novel approach to tissue property mapping.
Purpose Of The Study:
The study aims to evaluate a novel processing technology designed to map tissue susceptibility without the interference of blooming artifacts. Researchers sought to determine if this method could provide hematoma volume measurements independent of imaging parameters. This investigation addresses the significant problem of echo time dependence in conventional gradient echo MRI scans. The team hypothesized that their approach would eliminate the variability seen in standard diagnostic imaging protocols. They intended to compare their results against established techniques like susceptibility-weighted imaging and R2* mapping. By testing various echo times, they aimed to demonstrate the superior stability of their new mapping method. The motivation for this work stems from the need for more accurate and consistent quantification of brain hemorrhages in clinical settings. This effort seeks to establish a more reliable diagnostic standard for patients suffering from acute intracranial bleeding.
Main Methods:
The review approach involved analyzing gradient echo MRI data from sixteen patients diagnosed with intracerebral hemorrhage. Investigators processed these images using three distinct techniques to evaluate volume measurement stability. They generated susceptibility-weighted imaging, R2* maps, and the novel susceptibility-based processing method for comparison. The team systematically varied echo times during the scanning procedure to test parameter dependence. They applied linear regression models to correlate measured volume changes against these specific timing variations. A semiautomated segmentation tool served as the primary instrument for extracting volume data from all processed images. This design allowed for a direct comparison between the new technique and conventional diagnostic standards. The researchers focused on quantifying the slope of volume changes to determine the robustness of each imaging approach.
Main Results:
The strongest finding indicates that the new mapping technique maintains a nearly zero slope of 0.01±0.05 across varying echo times. In contrast, standard gradient echo magnitude images exhibited a substantial slope of 0.45±0.31. Susceptibility-weighted imaging showed a similar instability with a slope of 0.52±0.46. R2* mapping also performed poorly with a slope of 0.39±0.30. At an echo time of 20 ms, the new method yielded a volume 0.80 times that of the gradient echo magnitude. The correlation between these two methods reached an R-squared value of 0.99. These results confirm that the novel approach eliminates the echo time dependence observed in traditional scans. The data suggest that this technology provides a highly reliable measurement of hemorrhage volume.
Conclusions:
The authors propose that their mapping technology offers a stable solution for measuring intracranial bleeding. This approach removes the influence of timing parameters that previously hindered accurate volume assessments. Their data suggest that this method maintains consistency where standard imaging techniques fail. The researchers emphasize that their tool provides reliable measurements for clinical applications. They indicate that the semiautomated segmentation process enhances the speed of diagnostic workflows. The findings support the adoption of this technique to improve patient monitoring after hemorrhage events. This synthesis highlights the potential for more precise quantification in neuroimaging practice. These results demonstrate that susceptibility-based mapping effectively overcomes traditional limitations in gradient echo analysis.
The researchers propose that this mapping technology eliminates echo time dependence, unlike traditional gradient echo magnitude or R2* imaging. While standard methods show significant volume variation across different timing settings, this approach maintains a nearly zero slope, ensuring consistent and reliable measurements for clinicians.
The authors utilize a semiautomated segmentation tool to process the images. This software component allows for rapid and accurate identification of the hemorrhage boundaries, which facilitates more efficient clinical workflows compared to manual tracing methods often required in conventional diagnostic radiology.
Gradient echo MRI is necessary because it provides the raw signal data required for calculating susceptibility maps. Without these specific sequences, the researchers could not derive the R2* values or perform the susceptibility-weighted imaging needed to compare against their novel processing technique.
The researchers use susceptibility-weighted imaging and R2* mapping as comparative data types. These established methods serve as benchmarks to demonstrate how their new technique reduces blooming artifacts and provides more stable volume estimates across varying echo times.
The researchers measured the slope of hematoma volume versus echo time. They found a substantial slope of 0.45 for gradient echo magnitude, whereas the new mapping technique showed a nearly zero slope of 0.01, indicating significantly higher stability across different imaging parameters.
The authors claim that this technology provides a reliable, rapid, and accurate method for quantifying hemorrhage size. They suggest that implementing this approach will improve clinical diagnostic precision by removing the variability inherent in traditional gradient echo imaging protocols.
